A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Sibutramine
Diethylnorspermine
Lofexidine may decrease the antihypertensive activities of Diethylnorspermine.
Sibutramine
Ambrisentan
Lofexidine may decrease the antihypertensive activities of Ambrisentan.
Sibutramine
Sitaxentan
Lofexidine may decrease the antihypertensive activities of Sitaxentan.
Sibutramine
Saprisartan
Lofexidine may decrease the antihypertensive activities of Saprisartan.
Sibutramine
Rescinnamine
Lofexidine may decrease the antihypertensive activities of Rescinnamine.
Sibutramine
Trimethaphan
Lofexidine may decrease the antihypertensive activities of Trimethaphan.
Sibutramine
Siponimod
Siponimod may decrease the antihypertensive activities of Lofexidine.
Sibutramine
Epicaptopril
Epicaptopril may decrease the antihypertensive activities of Lofexidine.
Sibutramine
Obinutuzumab
Lofexidine may increase the hypotensive activities of Obinutuzumab.
Sibutramine
Diazoxide
Diazoxide may increase the hypotensive activities of Lofexidine.
Sibutramine
Amifostine
Lofexidine may increase the hypotensive activities of Amifostine.
Sibutramine
Teriflunomide
The serum concentration of Lofexidine can be decreased when it is combined with Teriflunomide.
Sibutramine
Deferasirox
The serum concentration of Lofexidine can be increased when it is combined with Deferasirox.
Sibutramine
Ivabradine
Ivabradine may increase the QTc-prolonging activities of Lofexidine.
Arbutamine
Relugolix
The serum concentration of Relugolix can be increased when it is combined with Flibanserin.
Arbutamine
Pralsetinib
The serum concentration of Pralsetinib can be increased when it is combined with Flibanserin.
Arbutamine
Satralizumab
The serum concentration of Flibanserin can be decreased when it is combined with Satralizumab.
Arbutamine
Oliceridine
The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Flibanserin is combined with Oliceridine.
Arbutamine
Abametapir
The serum concentration of Flibanserin can be increased when it is combined with Abametapir.
Arbutamine
Tucatinib
The metabolism of Tucatinib can be decreased when combined with Flibanserin.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3